Logo image of HMPT

HOME POINT CAPITAL INC (HMPT) Stock Fundamental Analysis

NASDAQ:HMPT - Nasdaq - US43734L1061 - Common Stock - Currency: USD

2.32  0 (0%)

Fundamental Rating

3

HMPT gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 99 industry peers in the Financial Services industry. While HMPT seems to be doing ok healthwise, there are quite some concerns on its profitability. HMPT is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

HMPT had negative earnings in the past year.
In the past year HMPT had a positive cash flow from operations.
In multiple years HMPT reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: HMPT reported negative operating cash flow in multiple years.
HMPT Yearly Net Income VS EBIT VS OCF VS FCFHMPT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 0 2B -2B

1.2 Ratios

The profitability ratios for HMPT are negative, so there is not much use analyzing them.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
HMPT Yearly ROA, ROE, ROICHMPT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 0 20 -20 40 60

1.3 Margins

HMPT has a better Gross Margin (56.92%) than 78.72% of its industry peers.
HMPT's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for HMPT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 56.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.61%
GM growth 5YN/A
HMPT Yearly Profit, Operating, Gross MarginsHMPT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 0 20 -20 40 60 80

More info and screens

5

2. Health

2.1 Basic Checks

HMPT does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for HMPT has been reduced compared to 1 year ago.
The debt/assets ratio for HMPT has been reduced compared to a year ago.
HMPT Yearly Shares OutstandingHMPT Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 20M 40M 60M 80M 100M
HMPT Yearly Total Debt VS Total AssetsHMPT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2B 4B 6B

2.2 Solvency

HMPT has an Altman-Z score of 0.16. This is a bad value and indicates that HMPT is not financially healthy and even has some risk of bankruptcy.
HMPT has a Altman-Z score of 0.16. This is in the lower half of the industry: HMPT underperforms 62.77% of its industry peers.
HMPT has a debt to FCF ratio of 0.73. This is a very positive value and a sign of high solvency as it would only need 0.73 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 0.73, HMPT belongs to the top of the industry, outperforming 89.36% of the companies in the same industry.
A Debt/Equity ratio of 2.77 is on the high side and indicates that HMPT has dependencies on debt financing.
Looking at the Debt to Equity ratio, with a value of 2.77, HMPT is doing worse than 84.04% of the companies in the same industry.
Although HMPT does not score too well on debt/equity it has very limited outstanding debt, which is well covered by the FCF. We will not put too much weight on the debt/equity number as it may be because of low equity, which could be a consequence of a share buyback program for instance. This needs to be investigated.
Industry RankSector Rank
Debt/Equity 2.77
Debt/FCF 0.73
Altman-Z 0.16
ROIC/WACCN/A
WACC3.25%
HMPT Yearly LT Debt VS Equity VS FCFHMPT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 0 2B -2B

2.3 Liquidity

A Current Ratio of 1.53 indicates that HMPT should not have too much problems paying its short term obligations.
With a decent Current ratio value of 1.53, HMPT is doing good in the industry, outperforming 64.89% of the companies in the same industry.
HMPT has a Quick Ratio of 1.53. This is a normal value and indicates that HMPT is financially healthy and should not expect problems in meeting its short term obligations.
With a decent Quick ratio value of 1.53, HMPT is doing good in the industry, outperforming 67.02% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.53
Quick Ratio 1.53
HMPT Yearly Current Assets VS Current LiabilitesHMPT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 1B 2B 3B 4B 5B

More info and screens

4

3. Growth

3.1 Past

The earnings per share for HMPT have decreased strongly by -1166.67% in the last year.
The Revenue for HMPT has decreased by -62.77% in the past year. This is quite bad
Measured over the past years, HMPT shows a small growth in Revenue. The Revenue has been growing by 2.62% on average per year.
EPS 1Y (TTM)-1166.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1312.5%
Revenue 1Y (TTM)-62.77%
Revenue growth 3Y2.62%
Revenue growth 5YN/A
Sales Q2Q%-58.55%

3.2 Future

Based on estimates for the next years, HMPT will show a very strong growth in Earnings Per Share. The EPS will grow by 35.98% on average per year.
Based on estimates for the next years, HMPT will show a quite strong growth in Revenue. The Revenue will grow by 9.62% on average per year.
EPS Next Y76.04%
EPS Next 2Y43.03%
EPS Next 3Y35.98%
EPS Next 5YN/A
Revenue Next Year-42.42%
Revenue Next 2Y-9.38%
Revenue Next 3Y9.62%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
HMPT Yearly Revenue VS EstimatesHMPT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
HMPT Yearly EPS VS EstimatesHMPT Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 0 1 -1 2 3 4

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

HMPT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Based on the Price/Forward Earnings ratio of 42.71, the valuation of HMPT can be described as expensive.
HMPT's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. HMPT is more expensive than 72.34% of the companies in the same industry.
HMPT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.30, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 42.71
HMPT Price Earnings VS Forward Price EarningsHMPT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

97.87% of the companies in the same industry are more expensive than HMPT, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 0.17
EV/EBITDA N/A
HMPT Per share dataHMPT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as HMPT's earnings are expected to grow with 35.98% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y43.03%
EPS Next 3Y35.98%

More info and screens

4

5. Dividend

5.1 Amount

HMPT has a Yearly Dividend Yield of 6.90%, which is a nice return.
Compared to an average industry Dividend Yield of 4.93, HMPT pays a better dividend. On top of this HMPT pays more dividend than 89.36% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 2.39, HMPT pays a better dividend.
Industry RankSector Rank
Dividend Yield 6.9%

5.2 History

HMPT does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
HMPT Yearly Dividends per shareHMPT Yearly Dividends per shareYearly Dividends per share 2021 2022 0.05 0.1 0.15

5.3 Sustainability

The earnings of HMPT are negative and hence is the payout ratio. HMPT will probably not be able to sustain this dividend level.
DP-1.8%
EPS Next 2Y43.03%
EPS Next 3Y35.98%
HMPT Yearly Income VS Free CF VS DividendHMPT Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2018 2019 2020 2021 2022 0 2B -2B

More info and screens

HOME POINT CAPITAL INC

NASDAQ:HMPT (7/31/2023, 8:00:01 PM)

2.32

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryFinancial Services
Earnings (Last)08-09 2023-08-09/bmo
Earnings (Next)11-08 2023-11-08/bmo
Inst Owners0.02%
Inst Owner Change0%
Ins Owners0.47%
Ins Owner Change0%
Market Cap321.25M
Analysts50.91
Price Target2.12 (-8.62%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.9%
Yearly Dividend0.08
Dividend Growth(5Y)N/A
DP-1.8%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-444.72%
Min EPS beat(2)-859.33%
Max EPS beat(2)-30.11%
EPS beat(4)0
Avg EPS beat(4)-417.72%
Min EPS beat(4)-859.33%
Max EPS beat(4)-30.11%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)2
Avg Revenue beat(2)78.31%
Min Revenue beat(2)55.97%
Max Revenue beat(2)100.65%
Revenue beat(4)4
Avg Revenue beat(4)44.91%
Min Revenue beat(4)11.46%
Max Revenue beat(4)100.65%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)9.12%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-14.24%
EPS NY rev (1m)-30.76%
EPS NY rev (3m)-30.76%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.5%
Revenue NY rev (1m)-10.88%
Revenue NY rev (3m)-10.88%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 42.71
P/S 0.88
P/FCF 0.17
P/OCF 0.17
P/B 0.68
P/tB 0.68
EV/EBITDA N/A
EPS(TTM)-2.24
EYN/A
EPS(NY)0.05
Fwd EY2.34%
FCF(TTM)13.71
FCFY591.06%
OCF(TTM)13.7
OCFY590.71%
SpS2.63
BVpS3.4
TBVpS3.4
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 56.92%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-6.61%
GM growth 5YN/A
F-Score4
Asset Turnover0.17
Health
Industry RankSector Rank
Debt/Equity 2.77
Debt/FCF 0.73
Debt/EBITDA N/A
Cap/Depr 9.26%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.53
Quick Ratio 1.53
Altman-Z 0.16
F-Score4
WACC3.25%
ROIC/WACCN/A
Cap/Depr(3y)122.93%
Cap/Depr(5y)102.17%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1166.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-1312.5%
EPS Next Y76.04%
EPS Next 2Y43.03%
EPS Next 3Y35.98%
EPS Next 5YN/A
Revenue 1Y (TTM)-62.77%
Revenue growth 3Y2.62%
Revenue growth 5YN/A
Sales Q2Q%-58.55%
Revenue Next Year-42.42%
Revenue Next 2Y-9.38%
Revenue Next 3Y9.62%
Revenue Next 5YN/A
EBIT growth 1Y-164.18%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year111.61%
EBIT Next 3Y39.06%
EBIT Next 5YN/A
FCF growth 1Y254.41%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y255.11%
OCF growth 3YN/A
OCF growth 5YN/A